Evidence map›Paper›PMID 25284152›Full record

ArticleCell2014

Coreceptor scanning by the T cell receptor provides a mechanism for T cell tolerance.

Ondrej Stepanek, Arvind S Prabhakar, Celine Osswald, Carolyn G King, Anna Bulek, Dieter Naeher, Marina Beaufils-Hugot, Michael L Abanto, Virginie Galati, Barbara Hausmann and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 164 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Parallel reactions on a single T cell receptor offer a robust kinetic proofreading mechanism.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Review
  9. The partitioning of TCR repertoires by thymic selection.The Journal of experimental medicine · 2024
    Review
  10. Differential roles of kinetic on- and off-rates in T-cell receptor signal integration revealed with a modified Fab'-DNA ligand.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Article
  12. Review
  13. Mathematical models of TCR initial triggering.Frontiers in immunology · 2024
    Review
  14. OT-I TCR Transgenic Mice to Study the Role of PTPN22 in Anti-cancer Immunity.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  15. Proofreading does not result in more reliable ligand discrimination in receptor signaling due to its inherent stochasticity.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The kinase occupancy of T cell coreceptors reconsidered.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Ondrej StepanekDepartments of Biomedicine and Nephrology, University Hospital Basel and University of Basel, 4031 Basel, Switzerland. Electronic address: ondrej.stepanek@unibas.ch.
Arvind S PrabhakarDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Celine OsswaldDepartments of Biomedicine and Nephrology, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
Carolyn G KingDepartments of Biomedicine and Nephrology, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
Anna BulekInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.
Dieter NaeherDepartments of Biomedicine and Nephrology, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
Marina Beaufils-HugotDepartments of Biomedicine and Nephrology, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
Michael L AbantoDepartments of Biomedicine and Nephrology, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
Virginie GalatiDepartments of Biomedicine and Nephrology, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
Barbara HausmannDepartments of Biomedicine and Nephrology, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
Rosemarie LangDepartments of Biomedicine and Nephrology, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
David K ColeInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.
Eric S HusebyDepartment of Pathology, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Andrew K SewellInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.
Arup K ChakrabortyDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Institute for Medical Engineering and Science, Departments of Physics, Chemistry, and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Ragon Institute of MGH, MIT, and Harvard, 400 Technology Square, Cambridge, MA 02139, USA.
Ed PalmerDepartments of Biomedicine and Nephrology, University Hospital Basel and University of Basel, 4031 Basel, Switzerland. Electronic address: ed.palmer@unibas.ch.
University Hospital of Basel · CHUniversity of Basel · CHCardiff University · GBMassachusetts Institute of Technology · USUniversity of Massachusetts Chan Medical School · US

Funding

Understand the metabolic fitness of naïve T cellsP01AI091580 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ARTHUR Robert SALOMON · 2011 to 2026
$31.1M
T cell and transgenic core U19AI109858 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SELIN, LIISA KAARINA · 2014 to 2018
$11.9M
Visualizing, Quantifying, and Modeling of T Cell Response to Listeria InfectionP01AI071195 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CHAKRABORTY, ARUP K. · 2006 to 2010
$8.1M
Origin and Control of Self-Reactive TCRsR01DK095077 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HUSEBY, ERIC S · 2012 to 2016
$1.8M
Biotechnology and Biological Sciences Research Council BB/H001085/1NIAID NIH HHS 1-P01-AI071195NIAID NIH HHS P01 AI071195NIAID NIH HHS P01 AI091580NIAID NIH HHS U19 AI109858NIDDK NIH HHS R01 DK095077NIDDK NIH HHS R01-DK095077Wellcome Trust 100327
6 · The paper itself

Abstract

In the thymus, high-affinity, self-reactive thymocytes are eliminated from the pool of developing T cells, generating central tolerance. Here, we investigate how developing T cells measure self-antigen affinity. We show that very few CD4 or CD8 coreceptor molecules are coupled with the signal-initiating kinase, Lck. To initiate signaling, an antigen-engaged T cell receptor (TCR) scans multiple coreceptor molecules to find one that is coupled to Lck; this is the first and rate-limiting step in a kinetic proofreading chain of events that eventually leads to TCR triggering and negative selection. MHCII-restricted TCRs require a shorter antigen dwell time (0.2 s) to initiate negative selection compared to MHCI-restricted TCRs (0.9 s) because more CD4 coreceptors are Lck-loaded compared to CD8. We generated a model (Lck come&stay/signal duration) that accurately predicts the observed differences in antigen dwell-time thresholds used by MHCI- and MHCII-restricted thymocytes to initiate negative selection and generate self-tolerance.

Indexed as

Immune ToleranceAnimalsAutoantigensHistocompatibility Antigens Class IHistocompatibility Antigens Class IIKineticsLymphocyte Specific Protein Tyrosine Kinase p56(lck)Markov ChainsMice, Inbred C57BLReceptors, Antigen, T-CellThymocytesAutoantigensHistocompatibility Antigens Class IHistocompatibility Antigens Class IILymphocyte Specific Protein Tyrosine Kinase p56(lck)Receptors, Antigen, T-Cell

Identifiers

PMID25284152
PMCPMC4304671
OpenAlexW2055736811

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.